Global Hemp Group Inc. announced that Stephen D. Barnhill Jr. has been appointed interim President & CEO effective immediately. Curt Huber, former President &CEO will remain as a Director of the Company and will oversee GHG's continuing industrial hemp related business segments. Mr. Barnhill is currently the Chief Operating Officer (COO) of Apollon Formularies, plc, a natural biologics drug discovery company publicly traded on the Aquis Exchange in London, UK.

As Apollon's COO, he is responsible for all company operations in Jamaica, the Caribbean and North America. Stephen will be stepping down from that position immediately to become the Interim CEO of Global Hemp Group. Stephen is the Co-Founder and President of Apollon Formularies Inc. a US corporation established in 2014.

He was instrumental in the international expansion of Apollon Formularies Inc. to Jamaica in 2015, co-founding Apollon Formularies Jamaica Ltd. with headquarters in the Faculty of Medical Sciences at the University of the West Indies, Mona in Kingston. Apollon Formularies Jamaica Ltd. has a suite of vertical medical cannabis licenses from the Cannabis License Authority (CLA) including Cultivation Research and Development (allowing clinical trials), Processing, and Retail Therapeutic, an International Cancer and Chronic Pain Institute (ICCPI) in Kingston operating with a team of licensed medical doctors, Natural Psychedelic Therapeutics Ltd. to treat patients with psilocybin and an international medical tourism facility on the sea in Negril which treats international patients coming to Jamaica for treatment with Apollon's natural biologic products. Mr. Barnhill was also involved in the expansion of Apollon to Europe transitioning the company to Apollon Formularies, plc, a publicly traded company on the Aquis Exchange in London, UK and was appointed COO of Apollon Formularies, plc.

Stephen was also Founder and CEO of CBev Ventures Inc., a medical cannabis beverage company offering the High Spirits brand of drinks.